Physician

Kamlesh Natvarlal Patel, M.D.

According to 2025 Medicare claims, Kamlesh Patel, M.D. (NPI: 1902897788) practices nephrology in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF COLUMBUS, P.C. (NPI: 1689767295; TIN: 581838897) and primary practice location at 31904-6863.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 736 traditional Medicare patients, billed 3,870 HCPCS/CPT codes, and received $361,232 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,732 prescription claims across 324 beneficiaries totaling $85,540 in drug costs, led by Cinacalcet Hcl (Cinacalcet Hcl). 2020 DME data shows 16 claims. Open Payments data shows 7 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $580,609 to $85,540. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	922	5,743	$480,914
2016	942	6,151	$497,158
2017	901	5,103	$425,978
2018	985	5,906	$498,576
2019	1,118	6,388	$523,029
2020	830	4,441	$406,249
2021	836	4,178	$418,631
2022	882	4,412	$415,108
2023	845	4,441	$404,824
2024	736	3,870	$361,232

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	366	3,013	$580,609
2016	367	3,028	$566,374
2017	320	2,769	$516,221
2018	306	2,308	$351,821
2019	295	1,958	$233,265
2020	283	1,681	$244,431
2021	273	1,310	$177,768
2022	291	1,389	$147,298
2023	321	1,636	$125,993
2024	324	1,732	$85,540

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	71	$4,029
2016	N/R	54	$1,189
2017	N/R	53	$1,387
2018	N/R	32	$1,150
2019	N/R	40	$2,991
2020	N/R	16	$204
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	228	411	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	254	819	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	348	637	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	201	561	$63
81002	Urinalysis, manual test	364	838	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cinacalcet Hcl	Cinacalcet Hcl	17	895	$13,543
Calcium Acetate	Calcium Acetate	148	6,054	$11,424
Sevelamer Carbonate	Sevelamer Carbonate	44	1,980	$9,087
Nifedipine Er	Nifedipine	115	6,738	$3,599
Potassium Chloride	Potassium Chloride	134	6,353	$2,121

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$30	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kamlesh Natvarlal Patel, M.D.?

Tedicare shows public-source Medicare data for Kamlesh Natvarlal Patel, M.D. (NPI 1902897788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kamlesh Natvarlal Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kamlesh Natvarlal Patel, M.D.?

Kamlesh Natvarlal Patel, M.D. is linked to NEPHROLOGY ASSOCIATES OF COLUMBUS, P.C. (billing NPI 1689767295) in the available physician profile data.

Does Kamlesh Natvarlal Patel, M.D. have Open Payments data?

Kamlesh Natvarlal Patel, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.